Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GoodRx vs Prime Health

GoodRx
Graded #116

Higher grade

vs+10.199999999999996
Prime Health
Graded #344

Lower grade

The verdict

GoodRx takes it — 69.6/100 to 59.4/100.

GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGoodRx +38
80
42
Dose & formulationGoodRx +6
70
64
Clinical oversightPrime Health +5
69
74
Labs & monitoringPrime Health +14
51
65
FulfillmentGoodRx +12
81
69
Contract termsGoodRx +14
55
41
GoodRx · left barPrime Health · right bar

The numbers

MetricGoodRxPrime Health
WeighScore69.6/10059.4/100
GradeCC
Scorecard rank#116#344
SemaglutideNot disclosed$299/mo (compounded)
Tirzepatide$299/mo (brand Zepbound)$399/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
GoodRx

Graded #116 · C

Strengths

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where it loses points

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves
Prime Health

Graded #344 · C

Strengths

  • LegitScript-certified platform
  • Flat pricing that does not rise as dosage increases
  • Bundle includes medication, labs, shipping, and unlimited clinician access
  • Money-back guarantee of at least 10% body-weight loss in 4 months
  • Fast 24-hour prescription review and 5-7 day delivery

Where it loses points

  • Compounded medications only; no FDA-approved brand options listed
  • Not available in Louisiana
  • Care delivered through third-party clinician groups, not in-house
  • Named compounding pharmacy not disclosed
  • No insurance accepted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard